CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival.
about
An EGFRvIII-targeted bispecific T-cell engager overcomes limitations of the standard of care for glioblastoma.Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy.Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12.Multi-modal imaging of tumor cellularity and Tryptophan metabolism in human Gliomas.VSIG4 is highly expressed and correlated with poor prognosis of high-grade glioma patients.Expression of antigen processing and presenting molecules in brain metastasis of breast cancer.Host response in tumor diagnosis and prognosis: importance of immunologists and pathologists allianceEpigenetic biomarkers of T-cells in human glioma.Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma.Human leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2'-deoxycytidine and interferon-γ treatments: results from a multicentric study.Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma.LOH in the HLA class I region at 6p21 is associated with shorter survival in newly diagnosed adult glioblastomaPD-1 blockade enhances the vaccination-induced immune response in gliomamiR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of gliomaA cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine model.Impact of Human Immunodeficiency Virus in the Pathogenesis and Outcome of Patients with Glioblastoma Multiforme.The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma.Pathologic and gene expression features of metastatic melanomas to the brainIdentification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.Cancer immunoediting in malignant glioma.The spectrum of vaccine therapies for patients with glioblastoma multiformeImmune classifications with cytotoxic CD8+ and Th17 infiltrates are predictors of clinical prognosis in glioblastoma.Immune infiltration of tumor microenvironment following immunotherapy for glioblastoma multiforme.Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response.Histamine deficiency promotes accumulation of immunosuppressive immature myeloid cells and growth of murine gliomasTCR Sequencing Can Identify and Track Glioma-Infiltrating T Cells after DC Vaccination.Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class.BRAF(V600E) mutation is a negative prognosticator in pediatric ganglioglioma.Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma.Tumor image-derived texture features are associated with CD3 T-cell infiltration status in glioblastoma.CD4+ and Perivascular Foxp3+ T Cells in Glioma Correlate with Angiogenesis and Tumor Progression.Immunophenotyping of pediatric brain tumors: correlating immune infiltrate with histology, mutational load, and survival and assessing clonal T cell response.Targeting Neoantigens in Glioblastoma: An Overview of Cancer Immunogenomics and Translational Implications.Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade.Glioblastoma: new therapeutic strategies to address cellular and genomic complexity.Role of Macrophages in Brain Tumor Growth and Progression.CNS cancer immunity cycle and strategies to target this for glioblastoma.Immune Microenvironment in Glioblastoma Subtypes.Transcriptional characterization of immunological infiltrates and their relation with glioblastoma patients overall survival.
P2860
Q33665884-00AB171B-B9FE-4F13-9A32-2361C87BB3CDQ33761585-BB49CFB4-99ED-4216-908A-833AC1F5561CQ34764143-AB11FAA6-1BBA-4C62-A602-DE13125D5140Q35696405-05995500-9BBA-4135-92D7-BC234380439FQ35923158-A4EA8A6C-B42F-4037-BBE4-354EB3BC1BF8Q35941343-E6183EA2-4DF6-41B6-B0BC-1693F56C7FDEQ36002622-8F4CA81F-8A1A-4606-8CD4-31199DA31398Q36457087-AF81627C-DA67-489B-8D25-A4B38A9C9362Q36484129-1BAFFAC4-6458-4AA6-9B48-0948130CE418Q36512160-278D158D-D4FD-464D-89EB-6FEEC2441E85Q36582874-3FDE45D5-8D91-43AA-B784-B22447A76684Q36639475-7C59392A-C859-42DC-8A73-C92D3BB781C0Q36745457-43C5781C-0C10-4C73-8243-087BB191281AQ37109193-5351BB18-D384-4FAF-B6E4-3CF1DBD9888FQ37191655-B45AEEE0-6F62-4C39-B7F5-D6A69B6D92CFQ37362636-1053F472-1FB2-4DAE-B5D9-880B7FB5B571Q37421034-E38B7295-E534-4D25-9DF1-1DFD2E7CEC4EQ37471704-22ABB381-4B21-44CB-9062-B8EA39F5B426Q37512029-FEAD6DD9-B611-4941-A7ED-21C755389AC5Q37687506-BDD271AE-9959-4D1E-90F2-2EB7C2067F47Q37986999-68F0E63D-25F8-45D5-9463-510A33D6A06CQ38035788-5331D69C-F9BA-427E-BED4-AEC5655448B2Q38691992-4F23CCC0-4393-4129-8FCF-B396E90D081CQ38864816-0EFAC01E-5515-4127-A3F0-04EA6A7346C6Q38912265-606C6ECB-B2B8-43AC-8254-7012DDCEDC89Q40449390-39834BC3-61AD-4B72-803E-47E9E1F451E3Q42169344-7942707A-D27D-4F18-94EE-7D37FBD11015Q42789833-6681C8A4-507B-4517-ADB0-300FAA817A20Q46190389-40AA24AA-B884-4F22-A6C2-77123C5DD3CDQ46586294-1F3E1519-2D7C-4CA8-AC1D-8E42474CA96EQ47102313-1DB61F42-F38C-4000-956A-CC3CF4149425Q47126472-FA0AF071-1F57-450A-B60F-86C0AF56653AQ47660305-AC305C99-7377-4305-8BBA-38487DA441D1Q50130464-DA5E47F4-35F1-4D57-9F2B-60C84F244EBBQ50423292-65CBE68A-6ACD-4252-B0BD-AF2AE2DD82B5Q52366335-16142D65-2ED2-47B4-BD6E-3A6F8727357BQ52628012-413B727D-0DCA-4EA5-8C19-3622C06586A6Q55259532-E575F34C-0845-479F-952B-FB8486F4AB52Q55261256-00503408-2480-4894-9B3F-268AE8AF231BQ55456894-95855BFB-FE86-4F48-B3F5-949A418C79CF
P2860
CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
CD8+ T-cell infiltrate in newl ...... iated with long-term survival.
@ast
CD8+ T-cell infiltrate in newl ...... iated with long-term survival.
@en
CD8+ T-cell infiltrate in newl ...... iated with long-term survival.
@nl
type
label
CD8+ T-cell infiltrate in newl ...... iated with long-term survival.
@ast
CD8+ T-cell infiltrate in newl ...... iated with long-term survival.
@en
CD8+ T-cell infiltrate in newl ...... iated with long-term survival.
@nl
prefLabel
CD8+ T-cell infiltrate in newl ...... iated with long-term survival.
@ast
CD8+ T-cell infiltrate in newl ...... iated with long-term survival.
@en
CD8+ T-cell infiltrate in newl ...... iated with long-term survival.
@nl
P2093
P2860
P1476
CD8+ T-cell infiltrate in newl ...... ciated with long-term survival
@en
P2093
Andrew T Parsa
John Wiencke
Margaret R Wrensch
Michael E Sughrue
Seunggu J Han
Tarik Tihan
P2860
P304
P356
10.1016/J.JOCN.2010.03.031
P50
P577
2010-08-19T00:00:00Z